Vienna 2931 January 2018 Improving national drug statistical systems Enrico Bisogno Chief Data Development and Dissemination Unit Research and Trend Analysis Branch Vision for a national statistical system on drugs ID: 1046042
Download Presentation The PPT/PDF document "Expert working group on improving drug..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
1. Expert working group on improving drug statistics and strengthening the Annual Report QuestionnaireVienna, 29-31 January 2018Improving national drug statistical systemsEnrico BisognoChief Data Development and Dissemination UnitResearch and Trend Analysis Branch
2. Vision for a national statistical system on drugs
3. Drugs are illicit, related activities are hidden, difficult to measureFrequently-used data are derived from administrative registersLack of resources/skills (e.g. forensic capacities)Coordination issues at national levelNew Psychoactive Substances (NPS)Gender-relevant dataVulnerable groups (leave no one behind)Cross-cutting challenges
4. Measuring drug use is still challenging: reluctance to disclose drug use habits, difficult to reach/count drug user groups A challenge within the challenge: measuring severe/high-risk useDrug consumed: individual consumption patterns (incl. poly-drug use) and overall drug consumptionDirect and indirect impact on health of drug users (e.g. drug related mortality)Treatment of drug use, typologies and coverage (Indicator SDG 3.5.1) Challenges in measuring drug demand
5. Drug production: for plant-based drugs, issues to translate cultivation into production synthetic drugs ?Drug seizures: probably the most available drug indicator, but many challenges of completeness and comparabilityPrice and purity: which methods and capacities to assess themNPS: Early warning systems, pre-requirement to produce dataAlternative development: which metrics are relevant? How to evaluate its impact?Challenges in measuring drug supply
6. Beyond health impact, what socio-economic consequences of drug use? (e.g.: this dimension/group is ‘invisible’ in national socio-economic data) Drug and criminal justice system beyond drug-related offences: what about criminal justice response and its effectiveness? what about the link between drug trafficking and OC?Drugs and the illegal economy: size and functioning of drug markets, money laundering and illicit financial flowsChallenges in measuring socio-economic impact of drugs
7. drug use surveysIndirect approaches to estimate drug use (incl. severe drug use)conducting waste water analysis to produce drug use metricsSDG indicator 3.5.1 on treatmentdata on drug availability (market analysis)drug cultivation/production and factors contributing to illicit crop cultivationmonitor impact of alternative developmentillicit financial flows linked to drug trafficking(…..)Methodological development and guidance
8. Capacity buildingWhich topics?……..……..Which activities?E-learning training toolsRegional/national workshopsSupport to national coordination mechanisms (observatories)…..
9. Needs for capacity building measures on drug demand data
10. Needs for capacity building measures on drug supply data
11. Thank youenrico.bisogno@un.org